3-(2-{[(Tert-butoxy)carbonyl]amino}phenyl)prop-2-enoic acid | 1224967-99-0

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 3-(2-{[(Tert-butoxy)carbonyl]amino}phenyl)prop-2-enoic acid
• 英文别名: (E)-3-[2-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]prop-2-enoic acid
• CAS: 1224967-99-0
• 化学式: C₁₄H₁₇NO₄
• 分子量: 263.293
• InChiKey: MYNBKPLRPWFTKD-CMDGGOBGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  75.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-(2-{[(Tert-butoxy)carbonyl]amino}phenyl)prop-2-enoic acid 在 1% Pd/C 、 氢气 作用下， 以 甲醇 为溶剂， 反应 2.0h， 以96%的产率得到(S)-2-tert-butoxycarbonylamino-phenylpropanoic acid
  参考文献：
  名称：

  Intramolecular Aldol Reaction of N-Acylated (2-Aminophenyl)-α-oxoacetic Acids: Rapid Access to Tri- and Tetracyclic 1,2-Dihydroquinolin-2(1H)-ones

  摘要：

  A four-step synthesis of tri- and tetracyclic 1,2-dihydroquinolin-2(1H)-ones via acylation of various substituted isatins with readily available N-Boc-protected amino-acids followed by an intramolecular aldol reaction and cyclization has been developed. The final products were obtained in moderate to excellent overall yields.

  DOI：

  10.1021/jo1003339
• 作为产物：
  描述：

  methyl (E)-3-(2-((tert-butoxycarbonyl)amino)phenyl)acrylate 在 水 、 lithium hydroxide 、 盐酸 作用下， 以 乙二醇二甲醚 、 水 为溶剂， 反应 1.0h， 以87%的产率得到3-(2-{[(Tert-butoxy)carbonyl]amino}phenyl)prop-2-enoic acid
  参考文献：
  名称：

  Intramolecular Aldol Reaction of N-Acylated (2-Aminophenyl)-α-oxoacetic Acids: Rapid Access to Tri- and Tetracyclic 1,2-Dihydroquinolin-2(1H)-ones

  摘要：

  A four-step synthesis of tri- and tetracyclic 1,2-dihydroquinolin-2(1H)-ones via acylation of various substituted isatins with readily available N-Boc-protected amino-acids followed by an intramolecular aldol reaction and cyclization has been developed. The final products were obtained in moderate to excellent overall yields.

  DOI：

  10.1021/jo1003339

文献信息

• THIENOPYRIMIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
  申请人：LES LABORATOIRES SERVIER

  公开号：US20150175623A1

  公开（公告）日：2015-06-25

  Compounds of formula (I): wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 12 , X, A and n are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

  式(I)的化合物，其中R1、R2、R3、R4、R5、R6、R7、R12、X、A和n的定义如说明中所述。含有该化合物的药物可用于治疗涉及凋亡缺陷的病理学，如癌症、自身免疫性疾病和免疫系统疾病。
• Thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them
  申请人：LES LABORATOIRES SERVIER

  公开号：US10278972B2

  公开（公告）日：2019-05-07

  Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R12, X, A and n are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

  式(I)化合物： 其中 R1、R2、R3、R4、R5、R6、R7、R12、X、A 和 n 如说明中所定义。 含有相同成分的药物产品，可用于治疗涉及细胞凋亡缺陷的病症，如癌症、自身免疫性疾病和免疫系统疾病。
• New thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them
  申请人：Les Laboratoires Servier

  公开号：EP2886545B1

  公开（公告）日：2016-06-29
• US5563162A
  申请人：——

  公开号：US5563162A

  公开（公告）日：1996-10-08
• US9670227B2
  申请人：——

  公开号：US9670227B2

  公开（公告）日：2017-06-06